Zuvius Launches Zinotecan in 100mg, and 40 mg
Admin / May 16, 2015 / Graphic, Illustration, Logo
Zuvius Launches Zinotecan in 100mg, and 40 mg, used in the treatment of Cancer.
ZINOTECAN (IRINOTECAN INJECTION IP)
Each ml contains:
Irinotecan Hydrochloride Trihydrate IP…. 20mg
Water for injection IP ……………………………. q.s.
- Irinotecan Hydrochloride is indicated is a component of first-line therapy in combination with 5-fluorouracil and Leucovorin for patients with metastatic carcinoma of the colon or rectum.
- Irinotecan Hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.
20 mg/mL Single-Use Vial
40 mg/2mL Single-Use Vial
100 mg/5mL Single-Use Vial
- Zuvius Lifescience Along with YouWeCan (Yuvraj Singh's NGO) has Initiated a Nation Wide Cancer Awareness Programme Mumbai, Maharashtra , India
- Zuvius Lifesciences & Youwecan Foundations Marathon Initiative at VJTI, Mumbai
- Zuvius Lifesciences Participated in Cancer Walk Rally
- Zuvius Launched Medico Legal Contents for Doctors and clinicians at their website
- Zuvius launches Zyrolbine